ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 77, 2026
   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2018, Volume 69, Issue 3, 621-626

https://doi.org/10.37358/RC.18.3.6162

Luminita Ageu, Cristina Talpos, Ghizela Kanalas, Simina Crisan, Carmen Lacramioara Zamfir, Vladimir Poroch, Mirela Anghel

Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment

Abstract:

We approach the theme of modern investigation and treatment strategies, based on biochemical, clinical-biological, metabolic, pharmacogenetic, neuro-imagistic, and neuroendocrine integrative correlations in the management of depressive disorders. Our main objective was to investigate: the biochemical brain metabolites [N-acetyl-aspartate (NAA), gamma-aminobutyric acid (GABA), aspartate (Asp), creatine (CR), glutamine (Gln), glicerophosphocholine (GPC), phosphocholine (PC), phosphocreatine (PCr), taurine (Tau), N-methyl-D-aspartate (N-MDA), serine, glycine, choline (Cho)]; the neuroimagistic and neurobiological markers and the metabolic abnormalities in correlation with the molecular pharmacogenetic testing in children and adolescents treated with antidepressant medication. Our research was conducted between 2009-2016 on 90 children and adolescents with depressive disorders -45 children-G1, who benefited of pharmacogenetic testing tailored pharmacotherapy, and 45 without pharmacogenetic testing-G2. The patients were also evaluated by MR spectroscopy at baseline and after pharmacotherapy. The efficacy of the chosen therapy in correlation with the pharmacogenetic testing was evaluated by the mean change in the CDRS (Child Depression Rating Scale) total scores, in the CGI-S/I (Clinical Global Impression Severity/Improvement), CGAS (Clinical Global Assessment of Functioning) and by the change of the relevant neurobiological markers and MR spectroscopy biochemical brain metabolites. Our results showed statistically significant differences in the clinical scores between the studied groups. Our research could represent a proof that the biochemical brain metabolites registered in depressive disorders modified values in the MR spectroscopy and the administration of antidepressants could determine metabolic and neuroendocrine abnormalities (changed lipid profiles, high insulin and plasma glucose levels, weight gain, obesity), especially when chosen without prior pharmacogenetic testing.
Keywords:
biochemical metabolites; N-acetyl aspartate (NAA); gama-aminobutyric acid (GABA); metabolic abnormalities; antidepressants; pharmacogenetic testing

Issue: 2018, Volume 69, Issue 3
Pages: 621-626
Publication date: 2018/4/15
https://doi.org/10.37358/RC.18.3.6162
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
AGEU, L., TALPOS, C., KANALAS, G., CRISAN, S., ZAMFIR, C.L., POROCH, V., ANGHEL, M., Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment, Rev. Chim., 69(3), 2018, 621-626.

Vancouver
Ageu L, Talpos C, Kanalas G, Crisan S, Zamfir CL, Poroch V, Anghel M. Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment. Rev. Chim.[internet]. 2018 Mar;69(3):621-626. Available from: https://doi.org/10.37358/RC.18.3.6162


APA 6th edition
Ageu, L., Talpos, C., Kanalas, G., Crisan, S., Zamfir, C.L., Poroch, V. & Anghel, M. (2018). Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment. Revista de Chimie, 69(3), 621-626. https://doi.org/10.37358/RC.18.3.6162


Harvard
Ageu, L., Talpos, C., Kanalas, G., Crisan, S., Zamfir, C.L., Poroch, V., Anghel, M. (2018). 'Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment', Revista de Chimie, 69(3), pp. 621-626. https://doi.org/10.37358/RC.18.3.6162


IEEE
L. Ageu, C. Talpos, G. Kanalas, S. Crisan, C.L. Zamfir, V. Poroch, M. Anghel, "Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment". Revista de Chimie, vol. 69, no. 3, pp. 621-626, 2018. [online]. https://doi.org/10.37358/RC.18.3.6162


Text
Luminita Ageu, Cristina Talpos, Ghizela Kanalas, Simina Crisan, Carmen Lacramioara Zamfir, Vladimir Poroch, Mirela Anghel,
Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment,
Revista de Chimie,
Volume 69, Issue 3,
2018,
Pages 621-626,
ISSN 2668-8212,
https://doi.org/10.37358/RC.18.3.6162.
(https://revistadechimie.ro/Articles.asp?ID=6162)
Keywords: biochemical metabolites; N-acetyl aspartate (NAA); gama-aminobutyric acid (GABA); metabolic abnormalities; antidepressants; pharmacogenetic testing


RIS
TY - JOUR
T1 - Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment
A1 - Ageu, Luminita
A2 - Talpos, Cristina
A3 - Kanalas, Ghizela
A4 - Crisan, Simina
A5 - Zamfir, Carmen Lacramioara
A6 - Poroch, Vladimir
A7 - Anghel, Mirela
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2018
VL - 69
IS - 3
SP - 621
EP - 626
UR - https://doi.org/10.37358/RC.18.3.6162
KW - biochemical metabolites
KW - N-acetyl aspartate (NAA)
KW - gama-aminobutyric acid (GABA)
KW - metabolic abnormalities
KW - antidepressants
KW - pharmacogenetic testing
ER -


BibTex
@article{RevCh2018P621,
author = {Ageu Luminita and Talpos Cristina and Kanalas Ghizela and Crisan Simina and Zamfir Carmen Lacramioara and Poroch Vladimir and Anghel Mirela},
title = {Correlations Between Neuroendocrine Disorders and Biochemical Brain Metabolites Alterations in Antidepressant Treatment},
journal = {Revista de Chimie},
volume = {69},
number = {3},
pages = {621-626},
year = {2018},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.18.3.6162},
url = {https://revistadechimie.ro/Articles.asp?ID=6162}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice